Lumira Ventures
Lumira Ventures, established in 2007, is a prominent North American venture capital firm specializing in healthcare and life sciences investments. Based in Toronto, with additional offices in Montreal, Vancouver, and Boston, the firm focuses on emerging, mid, and late-stage companies in biotechnology, biopharmaceuticals, medical devices, digital health, and consumer health sectors. Lumira Ventures invests between $5 million to $15 million, providing not only capital but also active board participation, access to funding sources, partners, and market access to maximize the value of its portfolio companies' technology pipelines. With a 30-year history, the firm has invested in over 100 healthcare companies and currently has a portfolio of 30+ active investee companies across Canada and the United States.
Puzzle Medical Devices
Series A in 2025
Puzzle Medical Devices Inc., founded in 2018 and based in Montreal, Canada, focuses on developing innovative heart pump technologies for treating advanced heart failure. The company's flagship product, the ModulHeart, is a modular percutaneous heart pump designed to reduce cardiac afterload and enhance renal perfusion in patients who are not candidates for heart transplant or surgical mechanical circulatory support. Its unique design allows for multiple pumps to be anchored in parallel within the descending aorta, facilitating hemodynamic support while minimizing risks associated with traditional procedures, such as bleeding and stroke. The ModulHeart aims to improve patient outcomes by providing sustained symptom relief, reducing hospital readmissions, and enhancing overall quality of life. Puzzle Medical has made significant progress, including completing its first-in-human study with positive results in cardiac and kidney function, receiving FDA Breakthrough Device Designation, and establishing a strong network of Key Opinion Leaders in the field.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.